Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,970 public trials 1,744 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

NCT00329082

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Haven, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States
View Trial Details
Completed

Pioglitazone in Alzheimer Disease

NCT00982202

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • University Hospitals of Cleveland Cleveland, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

NCT00880412

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Hôpital Privé Les Magnolias Ballainvilliers, France
  • Cabinet Médical Bergerac, France
  • Fleyriat Hospital Bourg-en-Bresse, France
  • Cabinet Médical Dijon, France
View all 22 locations
View Trial Details
Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

NCT00129181

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Department of Neurology, Innsbruck Medical University Innsbruck, Austria
  • Neurological Department, Wilhelminenspital Vienna, Austria
  • Dept. of Neurology, University of Leipzig Leipzig, Germany
  • Dept. of Neurology Marburg, Phillips-Univ. Marburg, Germany
View Trial Details

Related conditions